Recent understanding on diagnosis and management of central nervous system vasculitis in children

Clinical and Developmental Immunology

Volumn 2012, Issue , 2012, Pages

  Iannetti, Ludovico ^a   Zito, Roberta ^a   Bruschi, Simone ^a   Papetti, Laura ^a   Ulgiati, Fiorenza ^a   Nicita, Francesco ^a   Del Balzo, Francesca ^a   Spalice, Alberto ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ADALIMUMAB; AZATHIOPRINE; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CHLORAMBUCIL; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DIPYRIDAMOLE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; FIBRINOGEN RECEPTOR ANTAGONIST; GLUCOCORTICOID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; MAGNESIUM SULFATE; METHOTREXATE; METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PLACEBO; PREDNISONE; RITUXIMAB; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; WARFARIN;

ANAPHYLACTOID PURPURA; ARTICLE; AUTOIMMUNE DISEASE; BEHCET DISEASE; BONE MARROW TOXICITY; BRAIN ISCHEMIA; CENTRAL NERVOUS SYSTEM DISEASE; CENTRAL NERVOUS SYSTEM VASCULITIS; CEREBRAL SINUS THROMBOSIS; CEREBRAL VASOCONSTRICTION SYNDROME; CEREBROVASCULAR DISEASE; CHILD; COGNITIVE DEFECT; CORONARY ARTERY DISEASE; CORTICOSTEROID THERAPY; CYTAPHERESIS; DEMYELINATING DISEASE; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG POTENTIATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INTRACTABLE EPILEPSY; ISCHEMIA; LOW DRUG DOSE; LYMPHOMA; METABOLIC DISORDER; MUCOCUTANEOUS LYMPH NODE SYNDROME; MYOCARDITIS; NEOPLASM; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUTRITIONAL DISORDER; PLASMAPHERESIS; POLYARTERITIS NODOSA; PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM IN CHILDREN; PRIORITY JOURNAL; REMISSION; THROMBOEMBOLISM; THROMBOSIS; TUBERCULOSIS; VASCULAR DISEASE; VASCULITIS; VASOCONSTRICTION; BRAIN VASCULITIS; REVIEW;

CHILD; HUMANS; MUCOCUTANEOUS LYMPH NODE SYNDROME; POLYARTERITIS NODOSA; PURPURA, SCHOENLEIN-HENOCH; VASCULITIS, CENTRAL NERVOUS SYSTEM;

EID: 84867385421     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2012/698327     Document Type: Article

References (77)

1. Benseler S., Schneider R., Central nervous system vasculitis in children. Current Opinion in Rheumatology 2004 16 1 43 50 2-s2.0-0348047328 10.1097/00002281-200401000-00009 (Pubitemid 38041398)
2. Ozen S., Ruperto N., Dillon M. J., Bagga A., Barron K., Davin J. C., Kawasaki T., Lindsley C., Petty R. E., Prieur A. M., Ravelli A., Woo P., EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Annals of the Rheumatic Diseases 2006 65 7 936 941 2-s2.0-33745714543 10.1136/ard.2005.046300
3. Eleftheriou D., Cox T., Saunders D., Klein N. J., Brogan P. A., Ganesan V., Investigation of childhood central nervous system vasculitis: magnetic resonance angiography versus catheter cerebral angiography. Developmental Medicine and Child Neurology 2010 52 9 863 867 2-s2.0-77955159493 10.1111/j.1469-8749.2009.03591.x
4. Wahezi D. M., Gomes W. A., Ilowite N. T., Cranial nerve involvement with juvenile polyarteritis nodosa: clinical manifestations and treatment. Pediatrics 2010 126 3 e719 e722 2-s2.0-77956287090 10.1542/peds.2009-3331
5. Khellaf M., Hamidou M., Pagnoux C., Michel M., Brisseau J. M., Chevallier X., Cohen P., Guillevin L., Godeau B., Vasculitis restricted to the lower limbs: a clinical and histopathological study. Annals of the Rheumatic Diseases 2007 66 4 554 556 2-s2.0-34147209158 10.1136/ard.2006.065110 (Pubitemid 46580483)
6. Dillon M. J., Eleftheriou D., Brogan P. A., Medium-size-vessel vasculitis. Pediatric Nephrology 2010 25 9 1641 1652 2-s2.0-77955012849 10.1007/s00467-009-1336-1
7. Hashimoto H., Yano T., Kawanishi T., Tsuda H., Nagasawa T., Outcome of collagen vascular diseases by treatment with plasmapheresis. Therapeutic Apheresis 1998 2 4 268 272 2-s2.0-0031727386 (Pubitemid 28544142)
8. Guillevin L., Cevallos R., Durand-Gasselin B., Lhote F., Jarrousse B., Callard P., Treatment of glomerulonephritis in microscopic polyangiitis and Churg-Strauss syndrome: indications of plasma exchanges meta-analysis of 2 randomized studies on 140 patients, 32 with glomerulonephritis. Annales de Medecine Interne 1997 148 3 198 204 2-s2.0-0030738007
9. Ozen S., The spectrum of vasculitis in children. Best Practice Research in Clinical Rheumatology 2002 16 3 411 425 2-s2.0-0036653246 10.1016/S1521-6942(02)90237-8 (Pubitemid 36526652)
10. Gedalia A., Correa H., Kaiser M., Sorensen R., Steroid sparing effect of intravenous gamma globulin in a child with necrotizing vasculitis. American Journal of the Medical Sciences 1995 309 4 226 228 2-s2.0-0028935225
11. Eleftheriou D., Melo M., Marks S. D., Tullus K., Sills J., Cleary G., Dolezalova P., Ozen S., Pilkington C., Woo P., Klein N., Dillon M. J., Brogan P. A., Biologic therapy in primary systemic vasculitis of the young. Rheumatology 2009 48 8 978 986 2-s2.0-70149086501 10.1093/rheumatology/kep148
12. Gianviti A., Trompeter R. S., Barratt T. M., Lythgoe M. F., Dillon M. J., Retrospective study of plasma exchange in patients with idiopathic rapidly progressive glomerulonephritis and vasculitis. Archives of Disease in Childhood 1996 75 3 186 190 2-s2.0-0029786167 (Pubitemid 26313260)
13. Kuo H.-C., Yang K. D., Chang W.-C., Ger L.-P., Hsieh K.-S., Kawasaki disease: an update on diagnosis and treatment. Pediatrics and Neonatology 2012 53 1 4 11 2-s2.0-74949133102 10.1016/j.pedneo.2011.11.003
14. Galeotti C., Bayry J., Kone-Paut I., Kaveri S. V., Kawasaki disease: aetiopathogenesis and therapeutic utility of intravenous immunoglobulin. Autoimmunity Reviews 2010 9 6 441 448 2-s2.0-77949918846 10.1016/j.autrev.2009. 12.004
15. Uehara R., Belay E. D., Epidemiology of Kawasaki disease in Asia, Europe, and the United States. Journal of Epidemiology 2012 22 2 79 85 2-s2.0-79960537418 10.2188/jea.JE20110131
16. Newburger J. W., Takahashi M., Gerber M. A., Gewitz M. H., Tani L. Y., Burns J. C., Shulman S. T., Ferrieri P., Baltimore R. S., Wilson W. R., Baddour L. M., Levison M. E., Pallasch T. J., Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the committee on rheumatic fever, endocarditis, and Kawasaki disease, council on cardiovascular disease in the young, American Heart Association. Pediatrics 2004 114 6 1708 1733 2-s2.0-32044456976 10.1542/peds.2004-2182 (Pubitemid 41754943)
17. Kato H., Sugimura T., Akagi T., Sato N., Hashino K., Maeno Y., Kazue T., Eto G., Yamakawa R., Long-term consequences of Kawasaki disease: a 10- to 21-year follow-up study of 594 patients. Circulation 1996 94 6 1379 1385 2-s2.0-0029814477 (Pubitemid 26307269)
18. Tabarki B., Mahdhaoui A., Selmi H., Yacoub M., Essoussi A. S., Kawasaki disease with predominant central nervous system involvement. Pediatric Neurology 2001 25 3 239 241 2-s2.0-0034811201 10.1016/S0887-8994(01)00290-9 (Pubitemid 32913142)
19. Alves N. R., Magalhães C. M. R., Almeida R. D. F., Prospective study of kawasaki disease complications: review of 115 cases. Revista da Associacao Medica Brasileira 2011 57 3 295 300 2-s2.0-79959522811
20. García Norniella B., Morán Poladura M., Fernández Díaz M., Fernández Fernández E., Suárez Castaón C., Aseptic meningitis secondary to intravenous immunoglobulin treatment in Kawasaki disease. Anales de Pediatria 2011 75 1 79 80 2-s2.0-79959377820 10.1016/j.anpedi.2010.11.019
21. Takagi K., Umezawa T., Saji T., Morooka K., Matsuo N., Meningoencephalitis in Kawasaki disease. Brain and Development 1990 22 5 429 435 2-s2.0-0025074050 (Pubitemid 20306720)
22. Ichiyama T., Nishikawa M., Hayashi T., Koga M., Tashiro N., Furukawa S., Cerebral hypoperfusion during acute Kawasaki disease. Stroke 1998 29 7 1320 1321 2-s2.0-0031808006 (Pubitemid 28300063)
23. Mori M., Imagawa T., Hara R., Kikuchi M., Hara T., Nozawa T., Miyamae T., Yokota S., Efficacy and limitation of infliximab treatment for children with Kawasaki disease intractable to intravenous immunoglobulin therapy: report of an open-label case series. Journal of Rheumatology 2012 39 4 864 867 2-s2.0-84859464707 10.3899/jrheum.110877
24. Newburger J. W., Takahashi M., Beiser A. S., Burns J. C., Bastian J., Kyung Ja Chung, Colan S. D., Duffy C. E., Fulton D. R., Glode M. P., Mason W. H., Meissner H. C., Rowley A. H., Shulman S. T., Reddy V., Sundel R. P., Wiggins J. W., Colton T., Melish M. E., Rosen F. S., A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. New England Journal of Medicine 1991 324 23 1633 1639 2-s2.0-0025770788
25. Weng K.-P., Ou S.-F., Lin C.-C., Hsieh K.-S., Recent advances in the treatment of Kawasaki disease. Journal of the Chinese Medical Association 2011 74 11 481 484 2-s2.0-82055208192 10.1016/j.jcma.2011.09.001
26. Baumer J. H., Love S. J., Gupta A., Haines L. C., Maconochie I., Dua J. S., Salicylate for the treatment of Kawasaki disease in children. Cochrane Database of Systematic Reviews 2006 18 4, article CD004175 2-s2.0-39049181756
27. Gidding S. S., Shulman S. T., Diagnosis and management of children with Kawasaki disease. Heart Disease and Stroke 1994 3 4 210 215 2-s2.0-0028237547 (Pubitemid 24228833)
28. Imaizumi T., Kawasaki Y., Matsuura H., Matsumoto A., Takano K., Suyama K., Hashimoto K., Suzuki H., Hosoya M., Efficacy of steroid pulse, plasmapheresis, and mizoribine in a patient with focal segmental glomerulosclerosis. Pediatric Nephrology 2007 22 8 1215 1218 2-s2.0-34548394621
29. Blaisdell L. L., Hayman J. A., Moran A. M., Infliximab treatment for pediatric refractory Kawasaki disease. Pediatric Cardiology 2011 32 7 1023 1027 2-s2.0-77955479123
30. Rowley A. H., Shulman S. T., Recent advances in the understanding and management of kawasaki disease. Current Infectious Disease Reports 2010 12 2 96 102 2-s2.0-77953545816 10.1007/s11908-010-0091-6
31. Suzuki H., Terai M., Hamada H., Honda T., Suenaga T., Takeuchi T., Yoshikawa N., Shibuta S., Miyawaki M., Oishi K., Yamaga H., Aoyagi N., Iwahashi S., Miyashita R., Onouchi Y., Sasago K., Suzuki Y., Hata A., Cyclosporin a treatment for kawasaki disease refractory to initial and additional intravenous immunoglobulin. The Pediatric Infectious Disease Journal 2011 30 10 871 876 2-s2.0-79955882607 10.1097/INF.0b013e318220c3cf
32. O'Connor M. J., Saulsbury F. T., Incomplete and atypical Kawasaki disease in a young infant: severe, recalcitrant disease responsive to infliximab. Clinical Pediatrics 2007 46 4 345 348 2-s2.0-34247216142 10.1177/ 0009922806294842 (Pubitemid 46609103)
33. Oishi T., Fujieda M., Shiraishi T., Ono M., Inoue K., Takahashi A., Ogura H., Wakiguchi H., Infliximab treatment for refractory kawasaki disease with coronary artery aneurysmA 1-month-old girl. Circulation Journal 2008 72 5 850 852 2-s2.0-44149127696 10.1253/circj.72.850 (Pubitemid 351716695)
34. Weiss J. E., Eberhard B. A., Chowdhury D., Gottlieb B. S., Infliximab as a novel therapy for refractory Kawasaki disease. Journal of Rheumatology 2004 31 4 808 810 2-s2.0-1842425815 (Pubitemid 38451274)
35. Zulian F., Zanon G., Martini G., Mescoli G., Milanesi O., Efficacy of infliximab in long-lasting refractory Kawasaki disease. Clinical and Experimental Rheumatology 2006 24 4 453 2-s2.0-33748574875 (Pubitemid 44363551)
36. Suda K., Kudo Y., Sugawara Y., Ishii M., Matsuishi T., Prevention of thrombosis of coronary aneurysms in patients with a history of Kawasaki disease. Japanese Journal of Clinical Medicine 2008 66 2 355 359 2-s2.0-40949100045
37. Choueiter N. F., Olson A. K., Shen D. D., Portman M. A., Prospective open-label trial of etanercept as adjunctive therapy for kawasaki disease. Journal of Pediatrics 2010 157 6 960 966 2-s2.0-78449280363 10.1016/j.jpeds. 2010.06.014
38. Huang S. M., Weng K. P., Chang J. S., Lee W. Y., Huang S. H., Hsieh K. S., Effects of statin therapy in children complicated with coronary arterial abnormality late after Kawasaki diseasea pilot study. Circulation Journal 2008 72 10 1583 1587 2-s2.0-52749097905 10.1253/circj.CJ-08-0121
39. Gardner-Medwin J. M. M., Dolezalova P., Cummins C., Southwood T. R., Incidence of Henoch-Schönlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. The Lancet 2002 360 9341 1197 1202 2-s2.0-0037136944 10.1016/S0140-6736(02)11279-7 (Pubitemid 35232718)
40. Vogler C., Eliason S. C., Wood E. G., Glomerular membranopathy in children with IgA nephropathy and Henoch Schonlein purpura. Pediatric and Developmental Pathology 1999 2 3 227 235 2-s2.0-0032933111 10.1007/s100249900118 (Pubitemid 29236596)
41. Pillebout E., Nochy D., Thervet E., Henoch-Shönlein purpura. Nephrologie et Therapeutique 2009 5 7 663 675 2-s2.0-70749083846 10.1016/j.nephro.2009.02.001
42. Ozen S., Pistorio A., Iusan S. M., Bakkaloglu A., Herlin T., Brik R., Buoncompagni A., Lazar C., Bilge I., Uziel Y., Rigante D., Cantarini L., Hilario M. O., Silva C. A., Alegria M., Norambuena X., Belot A., Berkun Y., Estrella A. I., Olivieri A. N., Alpigiani M. G., Rumba I., Sztajnbok F., Tambic-Bukovac L., Breda L., Al-Mayouf S., Mihaylova D., Chasnyk V., Sengler C., Klein-Gitelman M., Djeddi D., Nuno L., Pruunsild C., Brunner J., Kondi A., Pagava K., Pederzoli S., Martini A., Ruperto N., EULAR/PRINTO/PRES criteria for Henoch- Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: final classification criteria. Annals of the Rheumatic Diseases 2010 69 5 798 806 2-s2.0-77951583607 10.1136/ard.2009.116657
43. Chen C. L., Chiou Y. H., Wu C. Y., Lai P. H., Chung H. M., Cerebral vasculitis in Henoch-Schonlein purpura: a case report with sequential magnetic resonance imaging changes and treated with plasmapheresis alone. Pediatric Nephrology 2000 15 3-4 276 278 2-s2.0-0033637748 10.1007/s004670000477
44. Belman A. L., Leicher C. R., Moshe S. L., Mezey A. P., Neurologic manifestations of Schoenlein-Henoch purpura: report of three cases and review of the literature. Pediatrics 1985 75 4 687 692 2-s2.0-0021825089 (Pubitemid 15079520)
45. Garzoni L., Vanoni F., Rizzi M., Simonetti G. D., Simonetti B. G., Ramelli G. P., Bianchetti M. G., Nervous system dysfunction in Henoch-Schönlein syndrome: systematic review of the literature. Rheumatology 2009 48 12 1524 1529 2-s2.0-75649084482 10.1093/rheumatology/kep282
46. Zhang H. L., Wu J., Posterior reversible encephalopathy syndrome associated with Henoch-Schönlein Purpura. Pediatric Emergency Care 2010 26 12 966 2-s2.0-78650503108 10.1097/PEC.0b013e3181fe9282
47. Sasayama D., Shimojima Y., Gono T., Kaneko K., Matsuda M., Ikeda S. I., Henoch-Schönlein purpura nephritis complicated by reversible posterior leukoencephalopathy syndrome. Clinical Rheumatology 2007 26 10 1761 1763 2-s2.0-36048934211 10.1007/s10067-006-0502-0
48. Hinchey J., Chaves C., Appignani B., Breen J., Pao L., Wang A., Pessin M. S., Lamy C., Mas J. L., Caplan L. R., A reversible posterior leukoencephalopathy syndrome. New England Journal of Medicine 1996 334 8 494 500 2-s2.0-13344284635 10.1056/NEJM199602223340803 (Pubitemid 26067737)
49. Dasarathi M., Birchall D., De San Lazaro C., Fawcett L. K., Eyre J. A., Henoch-Schönlein purpura with posterior reversible encephalopathy syndrome. Pediatric Neurology 2012 46 1 42 43 2-s2.0-84858374956 10.1016/j.pediatrneurol. 2011.10.006
50. Kawasaki Y., The pathogenesis and treatment of pediatric Henoch-Schönlein purpura nephritis. Clinical and Experimental Nephrology 2011 15 5 648 657 2-s2.0-84255172704 10.1007/s10157-011-0478-1
51. Mollica F., Li Volti S., Garozzo R., Russo G., Effectiveness of early prednisone treatment in preventing the development of nephropathy in anaphylactoid purpura. European Journal of Pediatrics 1992 151 2 140 144 2-s2.0-0026501855
52. Ronkainen J., Koskimies O., Ala-Houhala M., Antikainen M., Merenmies J., Rajantie J., Örmälä T., Turtinen J., Nuutinen M., Early prednisone therapy in Henoch-Schönlein purpura: a randomized, double-blind, placebo-controlled trial. Journal of Pediatrics 2006 149 2 241 247 2-s2.0-33746596579 10.1016/j.jpeds.2006.03.024 (Pubitemid 44144490)
53. Oki E., Tsugawa K., Suzuki K., Ito E., Tanaka H., Leukocytapheresis for the treatment of refractory Henoch-Schönlein purpura resistant to both prednisolone and intravenous immunoglobulin therapy. Rheumatology International 2008 28 8 823 824 2-s2.0-43449120941 10.1007/s00296-008-0559-y
54. Mendes D., Correia M., Barbedo M., Vaio T., Mota M., Gonalves O., Valente J., Behet's diseasea contemporary review. Journal of Autoimmunity 2009 32 3-4 178 188 2-s2.0-67349196503 10.1016/j.jaut.2009.02.011
55. Robinson A. B., Gallentine W. B., Rabinovich C. E., Pediatric neuro-Behet's disease responsive to adalimumab. Pediatric Neurology 2010 43 4 291 293 2-s2.0-77956593912 10.1016/j.pediatrneurol.2010.04.021
56. Atkinson M., Moore E., Altinok D., Acsadi G., Cerebral infarct in pediatric Neuro-Behet's disease. Journal of Child Neurology 2008 23 11 1331 1335 2-s2.0-54549085778 10.1177/0883073808318199
57. Mitra S., Koul R. L., Paediatric neuro-Behcet's disease presenting with optic nerve head swelling. British Journal of Ophthalmology 1999 83 9 1096 2-s2.0-0032846170 (Pubitemid 29433446)
58. Haghighi A. B., Safari A., Proposing an algorithm for treatment of different manifestations of neuro-Behcet's disease. Clinical Rheumatology 2010 29 6 683 686 2-s2.0-77954424768 10.1007/s10067-010-1414-6
59. Hatemi G., Silman A., Bang D., Bodaghi B., Chamberlain A. M., Gul A., Houman M. H., Kötter I., Olivieri I., Salvarani C., Sfikakis P. P., Siva A., Stanford M. R., Stübiger N., Yurdakul S., Yazici H., EULAR recommendations for the management of Behet disease. Annals of the Rheumatic Diseases 2008 67 12 1656 1662 2-s2.0-56749168836 10.1136/ard.2007.080432
60. Nichols J. C., Ince A., Akduman L., Mann E. S., Interferon-alpha 2a treatment of neuro-Behcet disease. Journal of Neuro-Ophthalmology 2001 21 2 109 111 2-s2.0-0034948570 (Pubitemid 32579050)
61. Fujikowa K., Aratake K., Kawakami A., Aramaki T., Iwanaga N., Izumi Y., Arima K., Kamachi M., Tamai M., Huang M., Nakamura H., Nishiura Y., Origuchi T., Ida H., Eguchi K., Successful treatment of refractory neuro-Behet's disease with infliximab: a case report to show its efficacy by magnetic resonance imaging, transcranial magnetic stimulation and cytokine profile. Annals of the Rheumatic Diseases 2007 66 1 136 137 2-s2.0-33845987973 10.1136/ard.2006.056804 (Pubitemid 46044876)
62. Alty J. E., Monaghan T. M., Bamford J. M., A patient with neuro-Behet's disease is successfully treated with etanercept: further evidence for the value of TNF α blockade. Clinical Neurology and Neurosurgery 2007 109 3 279 281 2-s2.0-33847031338 10.1016/j.clineuro.2006.11.002
63. Ribi C., Sztajzel R., Delavelle J., Chizzolini C., Efficacy of TNF α blockade in cyclophosphamide resistant neuro-Behet disease. Journal of Neurology, Neurosurgery and Psychiatry 2005 76 12 1733 1735 2-s2.0-28144449548 10.1136/jnnp.2004.055434 (Pubitemid 41697647)
64. Sarwar H., McGrath H. Jr., Espinoza L. R., Successful treatment of long-standing neuro-Behet's disease with infliximab. Journal of Rheumatology 2005 32 1 181 183 2-s2.0-11844278273 (Pubitemid 40092611)
65. Kikuchi H., Aramaki K., Hirohata S., Effect of infliximab in progressive Neuro-Behet's syndrome. Journal of the Neurological Sciences 2008 272 1-2 99 105 2-s2.0-48349083688 10.1016/j.jns.2008.05.002
66. Cantarini L., Tinazzi I., Caramaschi P., Bellisai F., Brogna A., Galeazzi M., Safety and efficacy of etanercept in children with juvenile-onset Behcet's disease. International Journal of Immunopathology and Pharmacology 2009 22 2 551 555 2-s2.0-67650433877
67. Borhani Haghighi A., Safari A., Tocilizumab may be a potential addition to our weapons against neuro-Behet's disease. Medical Hypotheses 2008 71 1 156 157 2-s2.0-44149120983 10.1016/j.mehy.2008.01.011
68. Berlit P., Diagnosis and treatment of cerebral vasculitis. Therapeutic Advances in Neurological Disorders 2010 3 1 29 42 2-s2.0-77953370047 10.1177/1756285609347123
69. Elbers J., Halliday W., Hawkins C., Hutchinson C., Benseler S. M., Brain biopsy in children with primary small-vessel central nervous system vasculitis. Annals of Neurology 2010 68 5 602 610 2-s2.0-78249267872 10.1002/ana.22075
70. Ozen S., Anton J., Arisoy N., Bakkaloglu A., Besbas N., Brogan P., García-Consuegra J., Dolezalova P., Dressler F., Duzova A., Ferriani V. P. L., Hilário M. O. E., Ibáez-Rubio M., Kasapcopur O., Kuis W., Lehman T. J. A., Nemcova D., Nielsen S., Oliveira S. K., Schikler K., Sztajnbok F., Terreri M. T., Zulian F., Woo P., Juvenile polyarteritis: results of a multicenter survey of 110 children. Journal of Pediatrics 2004 145 4 517 522 2-s2.0-5144230828 10.1016/j.jpeds.2004.06.046 (Pubitemid 39345990)
71. Calabrese L. H., Furlan A. J., Gragg L. A., Ropos T. J., Primary angiitis of the central nervous system: diagnostic criteria and clinical approach. Cleveland Clinic Journal of Medicine 1992 59 3 293 306 2-s2.0-0026777019
72. Hajj-Ali R. A., Furlan A., Abou-Chebel A., Calabrese L. H., Benign angiopathy of the central nervous system: cohort of 16 patients with clinical course and long-term followup. Arthritis Care and Research 2002 47 6 662 669 2-s2.0-0037115097 (Pubitemid 35461321)
73. Hajj-Ali R. A., Calabrese L. H., Central nervous system vasculitis. Current Opinion in Rheumatology 2009 21 1 10 18 2-s2.0-58149214065 10.1097/BOR.0b013e32831cf5e6
74. Calabrese L. H., Dodick D. W., Schwedt T. J., Singhal A. B., Narrative review: reversible cerebral vasoconstriction syndromes. Annals of Internal Medicine 2007 146 1 34 44 2-s2.0-33846925575 (Pubitemid 351650319)
75. Sen E. S., Leone V., Abinun M., Forsyth R., Ramesh V., Friswell M., O'Callaghan F., Ramanan A. V., Treatment of primary angiitis of the central nervous system in childhood with mycophenolate mofetil. Rheumatology 2010 49 4 806 811 2-s2.0-77955152496
76. Hutchinson C., Elbers J., Halliday W., Branson H., Laughlin S., Armstrong D., Hawkins C., Westmacott R., Benseler S. M., Treatment of small vessel primary CNS vasculitis in children: an open-label cohort study. The Lancet Neurology 2010 9 11 1078 1084 2-s2.0-77957967997 10.1016/S1474-4422(10)70243-X
77. Alba M. A., Espígol-Frigolé G., Prieto-González S., Tavera-Bahillo I., García-Martínez A., Butjosa M., Hernández-Rodríguez J., Cid M. C., Central nervous system vasculitis: still more questions than answers. Current Neuropharmacology 2011 9 3 437 448 2-s2.0-79961003358 10.2174/157015911796557920